Cargando…

N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency

N-terminal pro-brain natriuretic peptide (NT-proBNP) is a routinely used prognostic parameter in patients with pre-capillary pulmonary hypertension (PH). As it accumulates in the presence of impaired renal function, the clinical utility of NT-proBNP in PH patients with concomitant renal insufficienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Harbaum, Lars, Hennigs, Jan K., Baumann, Hans J., Lüneburg, Nicole, Griesch, Elisabeth, Bokemeyer, Carsten, Grünig, Ekkehard, Klose, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994009/
https://www.ncbi.nlm.nih.gov/pubmed/24751887
http://dx.doi.org/10.1371/journal.pone.0094263
_version_ 1782312649019621376
author Harbaum, Lars
Hennigs, Jan K.
Baumann, Hans J.
Lüneburg, Nicole
Griesch, Elisabeth
Bokemeyer, Carsten
Grünig, Ekkehard
Klose, Hans
author_facet Harbaum, Lars
Hennigs, Jan K.
Baumann, Hans J.
Lüneburg, Nicole
Griesch, Elisabeth
Bokemeyer, Carsten
Grünig, Ekkehard
Klose, Hans
author_sort Harbaum, Lars
collection PubMed
description N-terminal pro-brain natriuretic peptide (NT-proBNP) is a routinely used prognostic parameter in patients with pre-capillary pulmonary hypertension (PH). As it accumulates in the presence of impaired renal function, the clinical utility of NT-proBNP in PH patients with concomitant renal insufficiency remains unclear. In a retrospective approach, patients with pre-capillary PH (group I or IV) and concomitant renal insufficiency at time of right heart catheterization (glomerular filtration rate (GFR) ≤60 ml/min/1.73 m(2)) were identified out of all prevalent pre-capillary PH patients treated at a single center. Forty patients with renal insufficiency (25.8%) were identified and matched regarding hemodynamic parameters with a control group of 56 PH patients with normal renal function (GFR >60 ml/min/1.73 m(2)). Correlations of NT-proBNP levels with hemodynamic and prognostic parameters (time to clinical worsening and overall survival) were assessed. Overall, GFR correlated inversely with NT-proBNP and had the strongest influence on NT-proBNP levels in a stepwise multiple linear regression model including hemodynamic parameters and age (r(2) = 0.167). PH patients with renal insufficiency had significant higher levels of NT-proBNP (median: 1935 ng/l vs. 573 ng/l, p = 0.001). Nevertheless, NT-proBNP correlated with invasive hemodynamic parameters in these patients. Using higher cut-off values than in patients with preserved renal function, NT-proBNP levels were significantly associated with time to clinical worsening (>1660 ng/l, p = 0.001) and survival (>2212 ng/l, p = 0.047) in patients with renal insufficiency. Multivariate Cox’s proportional hazards analysis including established prognostic parameters, age and GFR confirmed NT-proBNP as an independent risk factor for clinical worsening in PH patients with renal insufficiency (hazard ratio 4.8, p = 0.007). Thus, in a retrospective analysis we showed that NT-proBNP levels correlated with hemodynamic parameters and outcome regardless of renal function. By using higher cut-off values, NT-proBNP seems to represent a valid clinical marker even in PH patients with renal insufficiency.
format Online
Article
Text
id pubmed-3994009
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39940092014-04-25 N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency Harbaum, Lars Hennigs, Jan K. Baumann, Hans J. Lüneburg, Nicole Griesch, Elisabeth Bokemeyer, Carsten Grünig, Ekkehard Klose, Hans PLoS One Research Article N-terminal pro-brain natriuretic peptide (NT-proBNP) is a routinely used prognostic parameter in patients with pre-capillary pulmonary hypertension (PH). As it accumulates in the presence of impaired renal function, the clinical utility of NT-proBNP in PH patients with concomitant renal insufficiency remains unclear. In a retrospective approach, patients with pre-capillary PH (group I or IV) and concomitant renal insufficiency at time of right heart catheterization (glomerular filtration rate (GFR) ≤60 ml/min/1.73 m(2)) were identified out of all prevalent pre-capillary PH patients treated at a single center. Forty patients with renal insufficiency (25.8%) were identified and matched regarding hemodynamic parameters with a control group of 56 PH patients with normal renal function (GFR >60 ml/min/1.73 m(2)). Correlations of NT-proBNP levels with hemodynamic and prognostic parameters (time to clinical worsening and overall survival) were assessed. Overall, GFR correlated inversely with NT-proBNP and had the strongest influence on NT-proBNP levels in a stepwise multiple linear regression model including hemodynamic parameters and age (r(2) = 0.167). PH patients with renal insufficiency had significant higher levels of NT-proBNP (median: 1935 ng/l vs. 573 ng/l, p = 0.001). Nevertheless, NT-proBNP correlated with invasive hemodynamic parameters in these patients. Using higher cut-off values than in patients with preserved renal function, NT-proBNP levels were significantly associated with time to clinical worsening (>1660 ng/l, p = 0.001) and survival (>2212 ng/l, p = 0.047) in patients with renal insufficiency. Multivariate Cox’s proportional hazards analysis including established prognostic parameters, age and GFR confirmed NT-proBNP as an independent risk factor for clinical worsening in PH patients with renal insufficiency (hazard ratio 4.8, p = 0.007). Thus, in a retrospective analysis we showed that NT-proBNP levels correlated with hemodynamic parameters and outcome regardless of renal function. By using higher cut-off values, NT-proBNP seems to represent a valid clinical marker even in PH patients with renal insufficiency. Public Library of Science 2014-04-21 /pmc/articles/PMC3994009/ /pubmed/24751887 http://dx.doi.org/10.1371/journal.pone.0094263 Text en © 2014 Harbaum et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Harbaum, Lars
Hennigs, Jan K.
Baumann, Hans J.
Lüneburg, Nicole
Griesch, Elisabeth
Bokemeyer, Carsten
Grünig, Ekkehard
Klose, Hans
N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency
title N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency
title_full N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency
title_fullStr N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency
title_full_unstemmed N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency
title_short N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency
title_sort n-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994009/
https://www.ncbi.nlm.nih.gov/pubmed/24751887
http://dx.doi.org/10.1371/journal.pone.0094263
work_keys_str_mv AT harbaumlars nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency
AT hennigsjank nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency
AT baumannhansj nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency
AT luneburgnicole nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency
AT grieschelisabeth nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency
AT bokemeyercarsten nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency
AT grunigekkehard nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency
AT klosehans nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency